Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TGFBR1 | P36897 | 13/20 | 0.46 |
| ▸ | ACVR1B | P36896 | 2/20 | 0.42 |
| ▸ | SMO | Q99835 | 2/20 | 0.40 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.39 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.39 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.37 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5907466 | 0.89 | TGFBR1 (0.41) | TGFBR1MAPK14 | |
| SCHEMBL6180723 | 0.82 | TGFBR1 (0.49) | TGFBR1ACVR1BCYP2C9CYP1A2CYP2D6 | |
| SCHEMBL6181800 | 0.82 | TGFBR1 (0.46) | TGFBR1ACVR1BCYP2C9CYP1A2CYP2D6 | |
| Gw679410X SCHEMBL376414 | 0.79 | TGFBR1 (0.63) | TGFBR1ACVR1B | |
| SCHEMBL373364 | 0.79 | TGFBR1 (0.70) | TGFBR1ACVR1BCYP2C9CYP1A2CYP2D6 | |
| SCHEMBL21932037 | 0.78 | TGFBR1 (0.66) | TGFBR1ACVR1BCYP2C9CYP1A2CYP2D6 | |
| SCHEMBL6327640 | 0.78 | TGFBR1 (0.40) | TGFBR1ACVR1BSMOMAPK14CYP2C9 | |
| SCHEMBL6182397 | 0.78 | SMO (0.40) | TGFBR1ACVR1BSMOMAPK14CYP2C9 | |
| Gw711782X SCHEMBL415902 | 0.77 | TGFBR1 (0.70) | TGFBR1ACVR1B | |
| SCHEMBL21932036 | 0.77 | TGFBR1 (0.49) | TGFBR1ACVR1BCYP2C9CYP1A2CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1355903-B1 | PYRAZOLE DERIVATIVES AGAINST TGF OVEREXPRESSION | SMITHKLINE BEECHAM CORP (US) | 2005-03-16 | — | — | EP | claimed |